Branching morphogenesis of the lung is controlled by well-orchestrated signaling cascades between the developing epithelial and mesenchymal compartments. However, the complex transcription factor interactions that regulate lung epithelial differentiation remain poorly understood. Thyroid transcription factor 1 (TTF1) and GATA6 have been implicated in differentiation of the distal pulmonary epithelium and we have clearly shown that Nuclear Factor I (NFI) regulates surfactant protein-C gene expression. We also identified NFI binding sites in the promoters of several other lung epithelial specific genes. Our preliminary data suggests that NFI interacts with both TTF1 and GATA6 and is critical for proper lung development and Type II cell maturation. All NFI family members are expressed in adult Type II cells, however genetic inactivation of Nfib, but not Nfia, causes neonatal death by respiratory failure due to a block in lung maturation. This proposal will test the hypothesis that NFIB coordinates the interaction of other transcription factors and cofactors to regulate distal lung morphogenesis, proliferation, and Type II cell specific gene expression. We hypothesize that NFI plays a major role in inhibiting cell proliferation during cytodifferentiation and in the adult lung. The goals of this proposal are to 1) determine the role of NFI in pulmonary epithelial cell proliferation and differentiation in vivo and in vitro using doxycycline regulated overexpression and """"""""dominant-repressor"""""""" strategies; 2) determine whether epithelial expression of a single isoform of Nfib in Nfib gene targeted mice is sufficient to induce progression of lung development and distal epithelial cytodifferentiation; 3) identify the protein-protein interactions that modulate NFI transcriptional activity in Type II cells. The current proposal will define novel molecular mechanisms by which NFI regulates epithelial cytodifferentiation and morphogenesis of the developing lung. These studies may provide a basis for the rational design of new treatment strategies for neonatal pulmonary disease and bronchopulmonary dysplasia. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL060907-06
Application #
6682530
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Gail, Dorothy
Project Start
1998-07-01
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
6
Fiscal Year
2003
Total Cost
$330,350
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Bein, Kiflai; Wesselkamper, Scott C; Liu, Xiangdong et al. (2009) Surfactant-associated protein B is critical to survival in nickel-induced injury in mice. Am J Respir Cell Mol Biol 41:226-36
Towne, J E; Krane, C M; Bachurski, C J et al. (2001) Tumor necrosis factor-alpha inhibits aquaporin 5 expression in mouse lung epithelial cells. J Biol Chem 276:18657-64